Stocktoria

Samsung Biologics Co.,Ltd. 207940.KS

KR · Korea Exchange · XKRX · stock · Healthcare · website

Samsung Biologics Co.,Ltd. statistics & valuation

Market cap₩71.84T
P / E40.3×
P / S15.8×
P / B9.6×
P / FCF93.0×
Net margin39.2%
Return on equity23.9%
FCF margin17.0%
Net debt₩778.2B
Enterprise value USD$51.2B
Earnings yield EBIT/EV2.8%
Return on capital24.3%
Graham number -80.1%₩310,543.89

Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value (₩310,543.89); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
26.60% 23.20% 31.00% 39.20% 2022202320242025
Gross margin (%)
48.90% 48.80% 48.90% 55.20% 2022202320242025
Operating margin (%)
32.80% 30.10% 37.80% 45.40% 2022202320242025
Return on equity (%)
8.90% 8.70% 9.90% 23.90% 2022202320242025
Shares outstanding
46.3M 46.3M 46.3M 46.3M 2022202320242025
Net debt (₩)
₩1.62T ₩1.54T ₩1.10T ₩778.24B 2022202320242025
Share buybacks (₩)
₩92.01B 2022202320242025
Return on assets (%)
4.80% 5.30% 6.20% 16.10% 2022202320242025
Free cash flow margin (%)
-1.90% 15.20% 8.10% 17.00% 2022202320242025
Debt / equity (×)
0.28× 0.19× 0.14× 0.12× 2022202320242025
EPS (₩)
₩11432.00 ₩12051.00 ₩15221.00 ₩26628.00 2022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

Samsung Biologics Co.,Ltd. trades at about 58.7× earnings — above its 10-year norm (10-year range 45.2×–65.5×, median 46.2×).

45.2× 65.5×

Shaded band = 10-year range (45.2×–65.5×); dot = today's 58.7×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022
Gross margin55.2%48.9%48.8%48.9%
Operating margin45.4%37.8%30.1%32.8%
Net margin39.2%31.0%23.2%26.6%
FCF margin17.0%8.1%15.2%-1.9%
Return on assets16.1%6.2%5.3%4.8%
Return on equity23.9%9.9%8.7%8.9%
Debt / equity0.08×0.09×0.02×0.11×
Current ratio1.741.431.331.54

Computed from company filings · KR · as of 2025-12-31. Figures in KRW. Facts plus Stocktoria's own computed scores — not investment advice.